Both 5-HT1A agonist and 5-HT2A antagonist were able to curtail ADHD-like behavior on par with alpha-2 adrenergic agonist treatment which is well known to minimize ADHD symptoms. The gene discussed is HTR1A; the disease is attention deficit-hyperactivity disorder.